Neuropharmacological activity of hydroalcoholic extract of leaves of Colocasia esculenta

References

• Amos S, Adzu B, Binda L, Wambebe C, Gamaniel K. (2001). Neuropharmacological effect of the aqueous extract of Sphaeranthus senegalensis in mice. J Ethnopharmacol, 78, 33–37.
   PubMed Web of Science ®Google Scholar
• Anisman H, Matheson K. (2005). Stress, depression, and anhedonia: Caveats concerning animal models. Neurosci Biobehav Rev, 29, 525–546.
   PubMed Web of Science ®Google Scholar
• Bhattamisra SK, Khanna VK, Agrawal AK, Singh PN, Singh SK. (2008). Antidepressant activity of standardised extract of Marsiela minuta Linn. J Ethnopharmacol, 117, 51–57.
   PubMed Web of Science ®Google Scholar
• Brown AC, Reitzenstein JE, Liu J, Jadus MR. (2005). The anti-cancer effects of poi (Colocasia esculenta) on colonic adenocarcinoma cells in vitro. Phytother Res, 19, 767–771.
   PubMed Web of Science ®Google Scholar
• Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H. (2000). Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med, 66, 3–6.
   PubMed Web of Science ®Google Scholar
• Calil CM, Marcondes FK. (2006). The comparison of immobility time in experimental rat swimming models. Life Sci, 79, 1712–1719.
   PubMed Web of Science ®Google Scholar
• Capasso A, De Feo V, De Simone F, Sorrentino L. (1996). Pharma-cological effects of aqueous extract from Valeriana adscendeus. Phytother Res, 10, 309–312.
   Web of Science ®Google Scholar
• CSIR (Council for Scientific and Industrial Research) (2005). The Wealth of India (Raw Materials). New Delhi, India: NISCAIR Press, 225.
   Google Scholar
• Dawson GR, Tricklebank MD. (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci, 16, 33–36.
   PubMed Web of Science ®Google Scholar
• Deakin JFW. (1983). Role of serotogenic system in escape, avoidance and other behaviors. In: Cooper SJ, ed. Theory in Psychopharmacology. London: Academic Press, 149–193.
   Google Scholar
• Detke MJ, Lucki I, Rickels M. (1995). Active behaviours in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 121, 66–72.
   PubMed Web of Science ®Google Scholar
• Dubois MA, Ilyas M, Wagner H. (1986). Cussonosides A and B, two triterpenes-saponins from Cussonia barteri. Planta Med, 52, 80–83.
   Google Scholar
• Emamghoreishi M, Khasaki M, Aazam MF. (2005). Coriandrum sativum: Evaluation of its anxiolytic effect in the elevated plus-maze. J Ethnopharmacol, 96, 365–370.
   PubMed Web of Science ®Google Scholar
• Grindley BA, Omoruyi F, Asemota HN, Morrisona A. (2002). Carbohydrate digestion and intestinal ATPases in streptozotocin-induced diabetic rats fed extract of yam (Dioscorea cayenensis) or dasheen (Colocasia esculenta). Nutr Res, 22, 333–341.
   Web of Science ®Google Scholar
• Herrera-Ruiz M, Roman-Ramos R, Zamilpa A, Tortoriello J, Jimenez-Ferrer JE. (2008). Flavonoids from Tilia americana with anxiolytic activity in plus-maze test. J Ethnopharmacol, 118, 312–317.
   PubMed Web of Science ®Google Scholar
• Hogg S. (1996). A review of the validity and variability of the elevated plus maze as an animal model of anxiety. Pharmacol Biochem Behav, 54, 21–30.
   PubMed Web of Science ®Google Scholar
• Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzano M, Tortoriello J, Wasowski C, Marder M, De Lima TC, Mora S. (2006). The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. J Ethnopharmacol, 105, 400–408.
   PubMed Web of Science ®Google Scholar
• Iwashina T, Konishi T, Takayama A, Fukada M, Ootani S. (1999). Isolation and identification of the flavonoids in the leaves of taro. Ann Tsukuba Bot Gard, 18, 71–74.
   Google Scholar
• Kirtikar KR, Basu BD. (2005). Indian Medicinal Plants. Vol. 4, Dehradun: International Book Distributors, 2615.
   Google Scholar
• Litchfield JT, Wilcoxon F. (1949). A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 96, 99–113.
   PubMed Web of Science ®Google Scholar
• Lloyd KG, Zivkovic B, Scatton B, Morselli PL, Bartholoni G. (1989). The GABAergic hypothesis of depression. Prog Neuropsycho-pharmacol Biol Psychiatry, 13, 341–351.
   PubMed Web of Science ®Google Scholar
• Masur J, Martz RMW, Carlini EA. (1971). Effects of acute and chronic administration of Cannabis sativa and (−) delta9-trans-tetrahydrocannabinol on the behavior of rats in an open-field arena. Psychopharmacology, 19, 388–397.
   PubMedGoogle Scholar
• Matthews K, Christmas D, Swan J, Sorrell E. (2005). Animal models of depression: Navigating through the clinical fog. Neurosci Biobehav Rev, 29, 503–513.
   PubMed Web of Science ®Google Scholar
• N’Gouemo P, Nguemby-Bina C, Baldy-Moulinier M. (1994). Some neuropharmacological effects of an ethanolic extract of Maprounea africana in rodents. J Ethnopharmacol, 43, 161–166.
   PubMed Web of Science ®Google Scholar
• Naughton M, Mulrooney JB, Leonard BE. (2000). A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol, 15, 397–415.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. (2007). Natural products as sources of new drugs over the last 25 years. J Nat Prod, 70, 461–477.
   PubMed Web of Science ®Google Scholar
• Padovan CM, Guimaraes FS. (2004). Antidepressant-like effects of NMDA-receptors antagonist injected into the dorsal hippocampus of rats. Pharmacol Biochem Behav, 77, 15–19.
   PubMed Web of Science ®Google Scholar
• Pellow S, Chopin P, File SE, Briley M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 14, 149–167.
   PubMed Web of Science ®Google Scholar
• Pellow S, File SE. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol Biochem Behav, 24, 525–529.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Anton G, Blavet N, Jalfre M. (1978a). Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol, 47, 379–391.
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Bertin A, Jalfre M. (1978b). “Behavioral despair” in rats and mice: Strain differences and the effects of imipramine. Eur J Pharmacol, 51, 291–294.
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Cao BJ, Dalvi A, Holmes A. (1997). Animal models of anxiety: An ethological perspective. Braz J Med Biol Res, 30, 289–304.
   PubMed Web of Science ®Google Scholar
• Shah BN, Nayak BS, Bhatt SP, Jalalpure SS, Seth AK. (2007). The anti-inflammatory activity of the leaves of Colocasia esculenta. Saudi Pharm J, 15, 228–232.
   Google Scholar
• Sukma M, Chaiyo C, Murakami Y, Tohda M, Matsumoto K, Watanabe H. (2002). CNS inhibitory effects of barakol, a constituent of Cassia siamia Lamk. J Ethnopharmacol, 83, 87–94.
   PubMed Web of Science ®Google Scholar
• Trease EG, Evans WC. (2008). Textbook of Pharmacognosy. 15th edn, New Delhi, India: Alden Press, 539–541.
   Google Scholar
• Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. (1994). Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav, 47, 1–4.
   PubMed Web of Science ®Google Scholar
• Zwanzger P, Rupprecht R. (2005). Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. J Psychiatry Neurosci, 30, 167–175.
   PubMed Web of Science ®Google Scholar